- RBC reports that Amazon (AMZN +0.7%) has canceled its pharmaceutical wholesaler application in Maine. Pundits and analysts say the action implies that the online juggernaut will not enter prescription drug distribution in the near term, opting instead for selling medical supplies, an activity that does not require a license in Maine.
- If, indeed, Amazon defers on the pharma side, RBC says it will be a positive for pharmacy operators and drug suppliers.
- Amazon has similar licenses in 15 states.
- Related tickers: (WBA -2%)(CVS -1.2%)(RAD -6.4%)(ABC -1.5%)(MCK -1.6%)(CAH -1.1%)